1-8 of 8
Jaromir Gumulec, MD
Close
Sort by
Journal Articles

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Tereza Popkova, MD, Katarina Hradska, MD, Jana Mihalyova, MD, Michaela Skorupova, Tomas Jelinek, MD, Juraj Duras, MD, Zdenek Koristek, MD PhD, Milan Navratil, MD, Katerina Benkova, MD, Hana Plonkova, MD, Jana Zuchnicka, MD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4757.
https://doi.org/10.1182/blood-2019-127011
Published: 2019
Journal Articles

The Role of VWF, FVIII, ADAMTS13 and Inflammatory Response in the Outcome of Acute Ischemic Stroke Mechanical Thrombectomy Procedure

Jaromir Gumulec, MD, Václav Procházka, MD, PhD, Tomáš Jonszta, MD, PhD, Daniel Czerný, MD, Martin Roubec, MD, Jirka Mačák, MD, PhD, Petra Kovářová, Mgr., Ivo Lochman, PhD, David Kaspřák, PhD, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 3613.
https://doi.org/10.1182/blood.V130.Suppl_1.3613.3613
Published: 2017
Journal Articles

Prediction of Progression of Smouldering into Therapy Requiring Multiple Myeloma By Easily Accessible Clinical Factors [in 527 Patients]

Roman Hajek, Prof, MD PhD, Viera Sandecka, MD, Anja Seckinger, MD PhD, Ivan Spicka, Prof. MD PhD, Vlastimil Scudla, prof, MD PhD, Evzen Gregora, MD, Jakub Radocha, MD PhD, Lucie Brozova, Jiri Jarkovsky, Doc, RNDr., PhD, Lucie Rihova, Aneta Mikulasova, David Starostka, MD, Lenka Walterova, MD, Dagmar Adamova, MD, Petr Kessler, MD, Martin Brejcha, MD, Ivan Vonke, MD, Jarmila Obernauerova, MD, Kamila Valentova, MD, Zdenek Adam, prof, MD PhD, Jiri Minarik, MD PhD, Jan Straub, MD, Jaromir Gumulec, MD, Anthony D. Ho, Prof., MD FRCPC, Jens Hillengass, MD, Hartmut Goldschmidt, Prof, MD, Vladimir Maisnar, As Prof, MD PhD, Dirk Hose, MD
Journal: Blood
Blood (2014) 124 (21): 2071.
https://doi.org/10.1182/blood.V124.21.2071.2071
Published: 2014
Journal Articles

Evaluation of Current Clinical Models for Risk of Progression from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma or Related Malignancies in 2028 Persons Followed in the Czech Republic

Viera Sandecka, MD, Zdenek Adam, prof, MD PhD, Ivan Spicka, Prof. MD PhD, Vlastimil Scudla, prof, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, As Prof, MD PhD, Lucie Brozova, Jiri Jarkovsky, Doc., Lucie Rihova, Aneta Mikulasova, David Starostka, MD, Lenka Walterova, MD, Dagmar Adamova, MD, Petr Kessler, MD, Martin Brejcha, MD, Ivan Vonke, MD, Jarmila Obernauerova, MD, Kamila Valentova, MD, Ludek Pour, Doc, MD PhD, Jiri Minarik, MD PhD, Jan Straub, MD, Jakub Radocha, MD PhD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3376.
https://doi.org/10.1182/blood.V124.21.3376.3376
Published: 2014
Journal Articles

Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group

Jiri Minarik, MD PhD, Petr Pavlicek, MD, Ludek Pour, Doc, MD PhD, Tomas Pika, MD PhD, Vladimir Maisnar, As Prof, MD PhD, Ivan Spicka, prof, MD PhD, Jiri Jarkovsky, RNDr, PhD, Marta Krejci, As Prof, MD PhD, Jaroslav Bacovsky, MD PhD, Jakub Radocha, MD PhD, Jan Straub, MD, Petr Kessler, MD, Marek Wrobel, MD, Lenka Walterova, MD, Michal Sykora, MD, Jarmila Obernauerova, MD, Evzen Gregora, MD, Dagmar Adamova, MD, Jaromir Gumulec, MD, Zdenek Adam, prof, MD PhD, Vlastimil Scudla, prof, MD PhD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2117.
https://doi.org/10.1182/blood.V124.21.2117.2117
Published: 2014
Journal Articles

Bortezomib (Velcade) in the Treatment of Relapsed or Refractory Multiple Myeloma: Analysis of Safety and Efficacy of Bortezomib From Registry of Monoclonal Gammopathy of Czech Myeloma Group

Viera Sandecka, MD, Ivan Spicka, As. Prof. MD, PhD, Vladimir Maisnar, As. Prof. MD, PhD, Tomas Pika, MD, PhD, Evzen Gregora, MD, David Starostka, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Ivan Vonke, MD, Lenka Zahradova, MD, PhD, Jan Straub, MD, Jakub Radocha, MD, PhD, Jiri Minarik, MD, PhD, Petr Pavlicek, MD, Petr Kessler, MD, Ludek Pour, MD, PhD, Roman Hajek, Prof. MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1872.
https://doi.org/10.1182/blood.V120.21.1872.1872
Published: 2012
Journal Articles

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Roman Hajek Prof, MD, Ivan Spicka, MD, PhD, Vlastimil Scudla, MD, Evzen Gregora, MD, Vladimir Maisnar, MD, PhD, Miroslava Schutzova, MD, Elena Tothova Prof, MD, Martin Mistrik, MD, PhD, Marta Krejci, MD, PhD, Jan Straub, MD, Jiri Minarik, MD, Jakub Radocha, MD, Vladimir Koza, MD, PhD, Petr Pavlicek, MD, Libuse Novosadova, MD, Hana Frankova, MD, Yvetta Stavarova, MD, Petr Kessler, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Adam Svobodnik, PhD, Dana Kralova, Zdenek Adam, MD
Journal: Blood
Blood (2007) 110 (11): 531.
https://doi.org/10.1182/blood.V110.11.531.531
Published: 2007
Journal Articles

Low Molecular Weight Heparin in Sufficient Dose of ≥70 IU/kg as an Effective and Safe Thromboprophylaxis in Patients with Newly Diagnosed Multiple Myeloma during Conventional VAD Induction Therapy.

Ludek Pour, MD, Petr Kessler, MD, Evzen Gregora, MD, Marketa Zemanova, MD, Miroslav Penka, MD, Jaromir Gumulec, MD, Zdenek Adam, MD, Bacovsky Jaroslav, MD, PhD, Hana Frankova, MD, Kamila Havlikova, MD, Frantisek Lehanka, MD, Vladimir Maisnar, PhD, Ivana Meluzinova, MD, Yvetta Stavarova, MD, Jan Straub, MD, Adam Svobodnik, PhD, Vlastimil Scudla, MD, Elena Sumna, MD, Lenka Walterova, MD, Roman Hajek, MD
Journal: Blood
Blood (2007) 110 (11): 2732.
https://doi.org/10.1182/blood.V110.11.2732.2732
Published: 2007